Meet 2024 Award Recipient
Jonathan Tyler Dullea
Jonathan completed dual degrees in Applied Mathematics and Chemistry at The University of Massachusetts where he won various academic awards including the Research Excellence in Theoretical Chemistry. Prior to attending Icahn, Jonathan worked at Vertex Pharmaceuticals on a team developing two now approved drugs for cystic fibrosis. He then completed dual Master of Science and Master of Public Health degrees at Boston University. Jonathan then started at Icahn School of Medicine in 2020.
While a student at Icahn, Jonathan spearheaded several research initiatives including a study characterizing nationwide disparities in palliative care utilization for patients with malignant brain tumors, and several studies of meningioma genomics. He presented at national conferences, has published 19 papers, won the Mount Sinai Neurosurgery Research Day Presentation award, and was a finalist in the 2022 MD++ “Datathon”. His research was partly supported by the competitive Medical Student Training in Aging Research (MSTAR) program. Jonathan also promoted equitable access to medicine through his role as a senior clinician at the East Harlem Health Outreach Partnership (EHHOP) student run free clinic.
Jonathan would like to thank to his family, partner, and friends for their support throughout his medical education. He would additionally like to extend his gratitude to his research mentor Dr. Shrivastava and his clinical mentors Dr. Soriano, Dr. Tomey, and Dr. Holzer for their invaluable guidance. Lastly, he would like to thank the class of 2024 for their camaraderie and commitment to excellence.
Jonathan will graduate with his M.D. degree and will remain at Mount Sinai for his internal medicine residency training.